People's Justice

Case trackerActive

Elmiron and claims for vision loss Updates

Updated Oct 7, 2026

Elmiron’s label warns of changes in the retina. If you have vision problems, talk to your doctor and ask a lawyer about your records.

Register interest

Follow the record

No source-linked updates are available here yet. The case guide has the current information and eligibility details.

Read the case guide

Stay informed

Get free updates about Elmiron and claims for vision loss

No phone call required. We will email you about relevant court filings, settlements, or important deadlines.

By submitting, you agree to receive email updates about this case. You can unsubscribe anytime. This is not legal advice, and we are not a law firm.

Sources

  1. ABA Model Rule 1.5: feesABA Model Rule 1.5: fees
  2. Southern District of New York: time limitsSouthern District of New York: time limits · court
  3. 45 CFR 164.524: access to health records45 CFR 164.524: access to health records · regulator
  4. Elmiron label on DailyMed, updated September 18, 2024Elmiron label on DailyMed, updated September 18, 2024 · regulator
  5. Wang et al: prospective PPS screening, 2021Wang et al: prospective PPS screening, 2021 · study
  6. Philadelphia Elmiron public docket, February 10, 2026 entryPhiladelphia Elmiron public docket, February 10, 2026 entry · court
  7. Elmiron federal CMO31, November 1, 2022Elmiron federal CMO31, November 1, 2022 · court

Want the complete picture?

Read the case guide for eligibility, evidence and your next steps.

View the full Elmiron and claims for vision loss case guide →